# OnCo record t-cell-histiocyte-rich-large-b-cell-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/t-cell-histiocyte-rich-large-b-cell-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "t-cell-histiocyte-rich-large-b-cell-lymphoma" ;
  schema:name "T-cell/histiocyte-rich large B-cell lymphoma"@en ;
  schema:alternateName "THRLBCL"@en, "T-cell/histiocyte-rich large B-cell lymphoma"@en, "T-cell-rich B-cell lymphoma"@en, "T-cell/histiocyte rich large B cell lymphoma"@en ;
  schema:description "A lymphoma in which the cancer cells are a tiny minority of what the pathologist sees: scattered large B cells in a dense crowd of normal T cells and macrophages. It is a form of large B-cell lymphoma, it usually presents with disease in the liver, spleen or bone marrow, and it is easy to mistake for a different disease in both directions."@en ;
  schema:url <https://onco.cc/cancers/t-cell-histiocyte-rich-large-b-cell-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Diffuse_large_B-cell_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1371/journal.pone.0078812>, <https://doi.org/10.1038/bjc.2015.94> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/mediastinal-grey-zone-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/fdg-pet/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:terms <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-b-versus-t-cell/>, <https://onco.cc/terms/lymphoma-indolent-versus-aggressive/>, <https://onco.cc/terms/ipi-score/> ;
  onco:standardOfCare <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/>, <https://onco.cc/targets/cd20/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/terms/r-chop/>, <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/> .